Sanofi R&D chief Houman Ashrafian is very sympathetic to the plight of cash-strapped biotechs but has implored companies not to skimp financially on the design and development of their clinical programs.
Speaking to delegates at the Swiss Biotech Day event in Basel earlier this week, Ashrafian said that his take-home message...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?